Oaktree Acquisition Corp. III Life Sciences (OACC) said Wednesday it priced its initial public offering of 17.5 million units at $10 per unit.
Each unit comprises one class A ordinary share and one-fifth of a redeemable warrant. Each warrant entitles the holder to purchase one class A share at $11.50 per share, according to the special purpose acquisition company.
The units will be listed on the Nasdaq Global Market this Thursday under the ticker symbol, "OACCU." Once the securities comprising the units begin trading separately, the class A shares and warrants will trade under the symbols "OACC" and "OACCW," respectively.
The offering is set to close Friday.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。